4-89724523-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000345.4(SNCA):​c.*2105G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.236 in 151,694 control chromosomes in the GnomAD database, including 7,218 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 7218 hom., cov: 31)
Failed GnomAD Quality Control

Consequence

SNCA
NM_000345.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0930

Publications

15 publications found
Variant links:
Genes affected
SNCA (HGNC:11138): (synuclein alpha) Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Alternatively spliced transcripts encoding different isoforms have been identified for this gene. [provided by RefSeq, Feb 2016]
SNCA Gene-Disease associations (from GenCC):
  • autosomal dominant Parkinson disease 4
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Parkinson disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • autosomal dominant Parkinson disease 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • Lewy body dementia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • hereditary late onset Parkinson disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • parkinsonian-pyramidal syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BP6
Variant 4-89724523-C-T is Benign according to our data. Variant chr4-89724523-C-T is described in ClinVar as [Benign]. Clinvar id is 350064.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.512 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SNCANM_000345.4 linkc.*2105G>A 3_prime_UTR_variant Exon 6 of 6 ENST00000394991.8 NP_000336.1 P37840-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SNCAENST00000394991.8 linkc.*2105G>A 3_prime_UTR_variant Exon 6 of 6 1 NM_000345.4 ENSP00000378442.4 P37840-1

Frequencies

GnomAD3 genomes
AF:
0.236
AC:
35785
AN:
151578
Hom.:
7203
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.514
Gnomad AMI
AF:
0.0714
Gnomad AMR
AF:
0.246
Gnomad ASJ
AF:
0.125
Gnomad EAS
AF:
0.530
Gnomad SAS
AF:
0.272
Gnomad FIN
AF:
0.103
Gnomad MID
AF:
0.207
Gnomad NFE
AF:
0.0700
Gnomad OTH
AF:
0.224
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.236
AC:
35842
AN:
151694
Hom.:
7218
Cov.:
31
AF XY:
0.239
AC XY:
17753
AN XY:
74142
show subpopulations
African (AFR)
AF:
0.514
AC:
21194
AN:
41244
American (AMR)
AF:
0.246
AC:
3753
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.125
AC:
433
AN:
3466
East Asian (EAS)
AF:
0.529
AC:
2718
AN:
5138
South Asian (SAS)
AF:
0.270
AC:
1296
AN:
4794
European-Finnish (FIN)
AF:
0.103
AC:
1085
AN:
10562
Middle Eastern (MID)
AF:
0.217
AC:
63
AN:
290
European-Non Finnish (NFE)
AF:
0.0700
AC:
4758
AN:
67954
Other (OTH)
AF:
0.227
AC:
477
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1099
2198
3296
4395
5494
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
334
668
1002
1336
1670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.170
Hom.:
638
Bravo
AF:
0.264
Asia WGS
AF:
0.427
AC:
1481
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Parkinson Disease, Dominant Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
1.6
DANN
Benign
0.27
PhyloP100
-0.093
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3857053; hg19: chr4-90645674; COSMIC: COSV105212776; COSMIC: COSV105212776; API